Literature DB >> 11417414

The role of gamma knife radiosurgery in children.

H G Eder1, K A Leber, S Eustacchio, G Pendl.   

Abstract

OBJECTS: Despite advances in microneurosurgery, the surgical management of deep-seated lesions is still associated with a high risk. Gamma knife radiosurgery (GKRS), however, has improved the outcome of cerebral tumors and arteriovenous malformations (AVMs) in delicate areas.
METHODS: Between March 1992 and June 1998, 50 children (age 1-16 years) with intracranial lesions were treated with GKRS. There were 12 low-grade gliomas, 12 high-grade gliomas, 7 craniopharyngiomas, 3 hamartomas, 2 meningiomas of the skull base, 2 vestibular schwannomas, 1 pituitary adenoma, 1 choroid plexus papilloma, and 10 AVMs. The mean size of the pathologies was 4.6 cm3 (range: 0.21-25.5 cm3). A mean marginal dose of 16 Gy (8-25 Gy) was applied to a mean isodose surface of 50% (35-90%). Clinical and neuroradiological follow-up were analyzed for outcome. Follow-up periods of 45 of these patients ranged from 8 to 79 months (mean 36 months); 5 patients were lost to follow-up. Neoplasms decreased in size in 15 cases (41%), remained unchanged in 13 patients (35%), and increased in 9 cases (24%). AVMs obliterated in 3 children (38%) within 24 months. Neurological follow-up demonstrated improved clinical status in 7 patients (15.5%), stable neurological status in 31 cases (69%) and clinical deterioration in 7 patients (15.5%). The treatment was well tolerated and no complications occurred.
CONCLUSIONS: GKRS represents a safe and effective treatment option for benign neoplasms or AVMs in pediatric patients and may extend survival times of children with malignant lesions.

Entities:  

Mesh:

Year:  2001        PMID: 11417414     DOI: 10.1007/s003810000435

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  Gamma knife radiosurgery for callosotomy in children with drug-resistant epilepsy.

Authors:  Hans Georg Eder; Michael Feichtinger; Tom Pieper; Senta Kurschel; Oskar Schroettner
Journal:  Childs Nerv Syst       Date:  2006-06-13       Impact factor: 1.475

2.  Neurovascular radiosurgery.

Authors:  M Söderman; W Y Guo; B Karlsson; D M Pelz; E Ulfarsson; T Andersson
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

3.  Metastatic atypical choroid plexus papilloma: a case report.

Authors:  Christopher E G Uff; Malcolm Galloway; Robert Bradford
Journal:  J Neurooncol       Date:  2006-09-06       Impact factor: 4.130

4.  Stereotactic radiotherapy and radiosurgery in pediatric patients: analysis of indications and outcome.

Authors:  Bilal Mirza; Anne Mønsted; Josephine Harding; Lars Ohlhues; Henrik Roed; Marianne Juhler
Journal:  Childs Nerv Syst       Date:  2010-07-29       Impact factor: 1.475

5.  Gamma knife radiosurgery for treatment resistant choroid plexus papillomas.

Authors:  In-Young Kim; Ajay Niranjan; Douglas Kondziolka; John C Flickinger; L Dade Lunsford
Journal:  J Neurooncol       Date:  2008-06-28       Impact factor: 4.130

6.  The role of up-front radiation therapy for incompletely resected pediatric WHO grade II low-grade gliomas.

Authors:  Kavita K Mishra; Dev R Puri; Brian T Missett; Kathleen R Lamborn; Michael D Prados; Mitchel S Berger; Anuradha Banerjee; Nalin Gupta; William M Wara; Daphne A Haas-Kogan
Journal:  Neuro Oncol       Date:  2006-02-22       Impact factor: 12.300

7.  Observed magnetic resonance imaging changes in pediatric patients treated with stereotactic radiosurgery for intracranial tumors.

Authors:  Sameer K Nath; Ruben Carmona; Brent S Rose; Daniel R Simpson; Michelle Russell; Joshua D Lawson; Arno J Mundt; Kevin T Murphy
Journal:  Childs Nerv Syst       Date:  2010-10-07       Impact factor: 1.475

8.  Initial clinical experience with frameless optically guided stereotactic radiosurgery/radiotherapy in pediatric patients.

Authors:  Sassan Keshavarzi; Hal Meltzer; Sharona Ben-Haim; Charles Benjamin Newman; Joshua D Lawson; Michael L Levy; Kevin Murphy
Journal:  Childs Nerv Syst       Date:  2009-03-27       Impact factor: 1.475

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.